Concentrations of Cytokines, Soluble Interleukin-2 Receptor, and Soluble CD30 in Sera of Patients with Hepatitis B Virus Infection during Acute and Convalescent Phases
- 1 November 2002
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 9 (6), 1372-5
- https://doi.org/10.1128/cdli.9.6.1372-1375.2002
Abstract
The immunoregulatory roles of interleukin-2 (IL-2), IL-4, IL-10, gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), the soluble form of the IL-2 receptor (sIL-2R), and the soluble form of CD30 (sCD30) were evaluated in patients with hepatitis B virus (HBV) infection. Two groups of subjects were studied: 15 healthy individuals without hepatitis antecedents and 15 patients with HBV infection. Blood samples were taken during the acute and convalescent phases. The analysis of the samples was done by the enzyme-linked immunosorbent assay technique. IFN-gamma and TNF-alpha levels decreased in the convalescent phase. IL-10, IL-2, and sIL-2R levels increased in the acute and convalescent phases, while sCD30 levels increased during the acute phase. The IL-4 concentrations decreased in both phases. During the acute phase, IFN-gamma and TNF-alpha induced increases in IL-2, sIL-2R, IL-10, and sCD30 levels in serum, which allowed the development of immunity characterized by the nonreactivity of the HBV surface antigen, the onset of antibodies to the HBV surface antigen (anti-HBs), and normal alanine aminotransferase levels during the convalescent phase. Increased IL-2 levels during the acute phase would stimulate the activities of NK cells and CD8(+) lymphocytes, which are responsible for viral clearing. The raised sIL-2R levels reveal activation of T lymphocytes and control of the IL-2-dependent immune response. The sCD30 increment during the acute phase reflects the greater activation of the Th2 cellular phenotype. Its decrease in the convalescent phase points out the decrease in the level of HBV replication. The increase in IL-10 levels could result in a decrease in IL-4 levels and modulate IFN-gamma and TNF-alpha levels during both phases of disease, allowing the maintenance of anti-HBs concentrations.Keywords
This publication has 37 references indexed in Scilit:
- Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the Trimera mouseHepatology, 2000
- Correlation of soluble interleukin-2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancerSurgery, 1996
- Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T LymphocytesImmunity, 1996
- Th1 and Th2 subsets: paradigms lost?Immunology Today, 1995
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Phenotypical analysis and cytokine release of liver‐infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiologyLiver International, 1994
- Soluble CD23 and Interleukin-4 Levels in Autoimmune Chronic Active Hepatitis and Systemic Lupus ErythematosusClinical Immunology and Immunopathology, 1994
- Cytokine profile of viral and autoimmune chronic active hepatitisJournal of Allergy and Clinical Immunology, 1993
- Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cellNature, 1979
- Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin GImmunochemistry, 1971